Ken Griffin Care Dx, Inc. Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Care Dx, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 24,000 shares of CDNA stock, worth $651,120. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,000

Previous 9,900 142.42%

Holding current value

$651,120

Previous $104,000 257.69%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$7.56 - $16.15 $305,726 - $653,106	40,440 Added 50.51%	120,501 $1.87 Million
Q1 2024 May 15, 2024	SELL	$7.96 - $12.37 $612,004 - $951,067	-76,885 Reduced 48.99%	80,061 $847,000
Q4 2023 Feb 14, 2024	SELL	$4.9 - $12.86 $180,217 - $472,977	-36,779 Reduced 18.99%	156,946 $1.88 Million
Q3 2023 Nov 14, 2023	BUY	$7.0 - $11.26 $522,116 - $839,860	74,588 Added 62.61%	193,725 $1.36 Million
Q2 2023 Aug 14, 2023	SELL	$7.61 - $9.46 $2.35 Million - $2.92 Million	-308,729 Reduced 72.16%	119,137 $1.01 Million
Q1 2023 May 15, 2023	BUY	$8.83 - $17.61 $1.79 Million - $3.57 Million	202,594 Added 89.93%	427,866 $3.91 Million
Q4 2022 Feb 14, 2023	SELL	$10.88 - $20.05 $2.47 Million - $4.54 Million	-226,589 Reduced 50.15%	225,272 $2.57 Million
Q3 2022 Nov 14, 2022	BUY	$16.06 - $26.39 $3.37 Million - $5.54 Million	209,979 Added 86.81%	451,861 $7.69 Million
Q2 2022 Aug 15, 2022	BUY	$20.49 - $39.72 $994,051 - $1.93 Million	48,514 Added 25.09%	241,882 $5.2 Million
Q1 2022 May 16, 2022	BUY	$28.19 - $46.6 $289,511 - $478,582	10,270 Added 5.61%	193,368 $7.15 Million
Q4 2021 Feb 14, 2022	SELL	$41.2 - $73.6 $8.49 Million - $15.2 Million	-206,024 Reduced 52.95%	183,098 $8.33 Million
Q3 2021 Nov 15, 2021	BUY	$59.15 - $91.99 $20.2 Million - $31.4 Million	341,204 Added 712.06%	389,122 $24.7 Million
Q2 2021 Aug 16, 2021	SELL	$63.02 - $95.11 $1.78 Million - $2.68 Million	-28,187 Reduced 37.04%	47,918 $4.39 Million
Q1 2021 May 17, 2021	BUY	$57.62 - $95.6 $2.96 Million - $4.91 Million	51,326 Added 207.14%	76,105 $5.18 Million
Q4 2020 Feb 16, 2021	SELL	$41.43 - $77.09 $1.3 Million - $2.41 Million	-31,258 Reduced 55.78%	24,779 $1.8 Million
Q3 2020 Nov 16, 2020	SELL	$30.88 - $37.94 $731,794 - $899,102	-23,698 Reduced 29.72%	56,037 $2.13 Million
Q1 2020 May 15, 2020	BUY	$13.94 - $28.25 $12,573 - $25,481	902 Added 1.14%	79,735 $1.74 Million
Q4 2019 Feb 14, 2020	SELL	$19.24 - $28.41 $1.46 Million - $2.16 Million	-76,116 Reduced 49.12%	78,833 $1.7 Million
Q3 2019 Nov 14, 2019	BUY	$20.03 - $40.08 $2.86 Million - $5.73 Million	142,918 Added 1187.91%	154,949 $3.5 Million
Q2 2019 Aug 14, 2019	SELL	$25.78 - $39.77 $1.43 Million - $2.21 Million	-55,602 Reduced 82.21%	12,031 $433,000
Q1 2019 May 15, 2019	BUY	$22.09 - $39.21 $914,901 - $1.62 Million	41,417 Added 157.98%	67,633 $0
Q2 2018 Aug 10, 2018	BUY	$7.93 - $15.79 $56,747 - $112,993	7,156 Added 37.54%	26,216 $0
Q1 2018 May 11, 2018	BUY	$5.18 - $7.97 $98,730 - $151,908	19,060 New	19,060 $152,000

Others Institutions Holding CDNA

# of Institutions

158

Shares Held

53.5M

Call Options Held

60.8K

Put Options Held

34.9K

View Full List

About CareDx, Inc.

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.45B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

More about CDNA

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account